Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion—a randomised study
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (13-14) , 2203-2208
- https://doi.org/10.1016/0959-8049(95)00425-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin.Thorax, 1993
- Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A Randomized TrialCancer, 1992
- Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.Journal of Clinical Oncology, 1991
- Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breastBritish Journal of Surgery, 1989
- Bio-Adhesio-Chemo (BAC) Therapy for Patients with Malignant Pleural EffusionAmerican Journal of Clinical Oncology, 1989
- Clinical Experience With Tetracycline Pleurodesis of Malignant Pleural EffusionsSouthern Medical Journal, 1987
- Tetracycline pleurodesis for malignant pleural effusions A 10-year retrospective studyCancer, 1987
- A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia.Journal of Clinical Oncology, 1987
- A CATHETER TECHNIQUE FOR INTRAPLEURAL ADMINISTRATION OF ALKYLATING AGENTS: A REPORT OF TEN CASESThe Lancet Healthy Longevity, 1962
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948